Showing 1 - 3 results of 3 for search 'Utid Suriya', query time: 0.01s Refine Results
  1. 1
    Correction: Suriya et al. Integration of In Silico Strategies for Drug Repositioning towards P38α Mitogen-Activated Protein Kinase (MAPK) at the Allosteric Site. <i>Pharmaceutics</i> 2022, <i>14</i>, 1461

    Correction: Suriya et al. Integration of In Silico Strategies for Drug Repositioning towards P38α Mitogen-Activated Protein Kinase (MAPK) at the Allosteric Site. <i>Pharmaceutics</... by Utid Suriya, Panupong Mahalapbutr, Thanyada Rungrotmongkol

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validation

    Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validation by Chawalit Ngernsombat, Utid Suriya, Pongphol Prattapong, Kanika Verma, Thanyada Rungrotmongkol, Thananya Soonkum, Sakonwan Kuhaudomlarp, Tavan Janvilisri

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Jorunnamycin A induces apoptosis in pancreatic ductal adenocarcinoma cells, spheroids, and patient-derived organoids by modulating KRAS-mediated survival pathways

    Jorunnamycin A induces apoptosis in pancreatic ductal adenocarcinoma cells, spheroids, and patient-derived organoids by modulating KRAS-mediated survival pathways by Hnin Ei Ei Khine, Utid Suriya, Thanyada Rungrotmongkol, Supakarn Chamni, Yanxi Lu, Alan Bénard, Bin Lan, Debabrata Mukhopadhyay, David Chang, Andrew Biankin, Regine Schneider-Stock, Robert Grützmann, Rungroch Sungthong, Christian Pilarsky, Chatchai Chaotham

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: